Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance-Reference-Cited by-同舟云学术

Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance

Published:2021-10-02 Issue:11 Volume:112 Page:4736-4747
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yamamuro Shun¹²,Takahashi Masamichi¹³^ORCID,Satomi Kaishi¹⁴,Sasaki Nobuyoshi¹⁵,Kobayashi Tatsuya¹⁶,Uchida Eita¹⁷,Kawauchi Daisuke¹⁸,Nakano Tomoyuki¹⁹¹⁰^ORCID,Fujii Takashi¹¹⁰¹¹,Narita Yoshitaka³,Kondo Akihide¹²,Wada Kojiro¹¹,Yoshino Atsuo²,Ichimura Koichi¹¹⁰^ORCID,Tomiyama Arata¹¹⁰¹¹^ORCID

Affiliation:

1. Division of Brain Tumor Translational Research National Cancer Center Research Institute Chuo‐ku Japan

2. Department of Neurological Surgery Nihon University School of Medicine Itabashi‐ku Japan

3. Department of Neurosurgery and Neuro‐Oncology National Cancer Center Hospital Chuo‐ku Japan

4. Department of Diagnostic Pathology National Cancer Center Hospital Chuo‐ku Japan

5. Department of Neurosurgery Faculty of Medicine Kyorin University Mitaka Japan

6. Department of Neurosurgery Tokyo Women’s Medical University Shinjuku‐ku Japan

7. Department of Neuro‐Oncology/Neurosurgery Saitama Medical University International Medical Center Hidaka‐City Japan

8. Department of Neurological Surgery Chiba University Graduate School of Medicine Chiba‐shi Japan

9. Department of Neurosurgery Tokyo Medical and Dental University Bunkyo‐ku Japan

10. Department of Brain Disease Translational Research Faculty of Medicine Juntendo University Bunkyo‐ku Japan

11. Department of Neurosurgery National Defense Medical College Tokorozawa Japan

12. Department of Neurosurgery Juntendo University School of Medicine Bunkyo‐ku Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15141

Reference57 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group

4. Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

5. A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma;Journal of Neuro-Oncology;2024-01-26

2. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy;Frontiers in Immunology;2024-01-11

3. Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human Glioblastoma cell lines;BIOIMPACTS;2023

4. Combination Therapy of Temozolomide, Ribavirin and Interferon-Beta for Glioblastoma In Vivo;Journal of Nihon University Medical Association;2023-10-01

5. Recurrent Glioblastoma: A Review of the Treatment Options;Cancers;2023-08-26